These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8589147)

  • 21. Anti-Fas2 IgM antibodies in Fasciola hepatica infected patients with positive IgG serology.
    Kazantseva L; García Lázaro MDP; Herrera-Velit P; Espinoza JR
    Trans R Soc Trop Med Hyg; 2017 Mar; 111(3):102-106. PubMed ID: 28633332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An approach of the laboratory to the field: assessment of the influence of cattle management on the seroprevalence of fascioliasis by using polyclonal- and recombinant-based ELISAs.
    Arias M; Piñeiro P; Hillyer GV; Suárez JL; Francisco I; Cortiñas FJ; Díez-Baños P; Morrondo P; Sánchez-Andrade R; Paz-Silva A
    J Parasitol; 2010 Jun; 96(3):626-31. PubMed ID: 19925039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A population-based coprological study of human fascioliasis in a hyperendemic area of the Bolivian Altiplano.
    Esteban JG; Flores A; Angles R; Strauss W; Aguirre C; Mas-Coma S
    Trop Med Int Health; 1997 Jul; 2(7):695-9. PubMed ID: 9270738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endemic human fasciolosis in the Bolivian Altiplano.
    Parkinson M; O'Neill SM; Dalton JP
    Epidemiol Infect; 2007 May; 135(4):669-74. PubMed ID: 17064455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for the presence of Fasciola hepatica antibodies in bulk-milk samples and their association with milk production decreases, in Cuban dairy cattle.
    Arenal A; García Y; Quesada L; Velázquez D; Sánchez D; Peña M; Suárez A; Díaz A; Sánchez Y; Casaert S; van Dijk J; Vercruysse J; Charlier J
    BMC Vet Res; 2018 Nov; 14(1):336. PubMed ID: 30409134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic uniformity, geographical spread and anthropogenic habitat modifications of lymnaeid vectors found in a One Health initiative in the highest human fascioliasis hyperendemic of the Bolivian Altiplano.
    Bargues MD; Artigas P; Angles R; Osca D; Duran P; Buchon P; Gonzales-Pomar RK; Pinto-Mendieta J; Mas-Coma S
    Parasit Vectors; 2020 Apr; 13(1):171. PubMed ID: 32252808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Indirect ultra-micro-ELISA for detecting IgG antibodies in patients with fascioliasis].
    Espino AM; Padrón L; Duménigo B; Laferté J
    Rev Cubana Med Trop; 1997; 49(3):167-73. PubMed ID: 9685983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High endemicity of human fascioliasis between Lake Titicaca and La Paz valley, Bolivia.
    Esteban JG; Flores A; Angles R; Mas-Coma S
    Trans R Soc Trop Med Hyg; 1999; 93(2):151-6. PubMed ID: 10450437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for Fasciola hepatica infection in children: a case-control study.
    Marcos L; Maco V; Samalvides F; Terashima A; Espinoza JR; Gotuzzo E
    Trans R Soc Trop Med Hyg; 2006 Feb; 100(2):158-66. PubMed ID: 16181652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological studies on Fasciola hepatica in Gafsa Oases (south west of Tunisia).
    Hammami H; Hamed N; Ayadi A
    Parasite; 2007 Sep; 14(3):261-4. PubMed ID: 17933307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasciola hepatica phenotypic characterization in Andean human endemic areas: valley versus altiplanic patterns analysed in liver flukes from sheep from Cajamarca and Mantaro, Peru.
    Valero MA; Perez-Crespo I; Khoubbane M; Artigas P; Panova M; Ortiz P; Maco V; Espinoza JR; Mas-Coma S
    Infect Genet Evol; 2012 Mar; 12(2):403-10. PubMed ID: 22285769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of MM3 monoclonal antibodies for the early immunodiagnosis of ovine fascioliasis.
    Mezo M; González-Warleta M; Ubeira FM
    J Parasitol; 2007 Feb; 93(1):65-72. PubMed ID: 17436943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluke egg characteristics for the diagnosis of human and animal fascioliasis by Fasciola hepatica and F. gigantica.
    Valero MA; Perez-Crespo I; Periago MV; Khoubbane M; Mas-Coma S
    Acta Trop; 2009 Aug; 111(2):150-9. PubMed ID: 19375410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sheep and Cattle Reservoirs in the Highest Human Fascioliasis Hyperendemic Area: Experimental Transmission Capacity, Field Epidemiology, and Control Within a One Health Initiative in Bolivia.
    Mas-Coma S; Buchon P; Funatsu IR; Angles R; Artigas P; Valero MA; Bargues MD
    Front Vet Sci; 2020; 7():583204. PubMed ID: 33195605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission patterns of Fasciola hepatica to ruminants in Sweden.
    Novobilský A; Engström A; Sollenberg S; Gustafsson K; Morrison DA; Höglund J
    Vet Parasitol; 2014 Jul; 203(3-4):276-86. PubMed ID: 24818749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short report: Diagnosis of human fascioliasis: detection of anti-cathepsin L antibodies in blood samples collected on filter paper.
    Strauss W; O'Neill SM; Parkinson M; Angles R; Dalton JP
    Am J Trop Med Hyg; 1999 May; 60(5):746-8. PubMed ID: 10344646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between eosinophilia, anti-Fasciola IgG, and IgM rheumatoid factors, in urban and rural areas of north-western Spain.
    Sánchez-Andrade A; Suárez JL; Arias M; Francisco I; Díez C; Cortiñas J; Romasanta A; Morrondo P; Díez-Baños P; Paz-Silva A; Sánchez-Andrade R
    Ann Trop Med Parasitol; 2008 Sep; 102(6):489-98. PubMed ID: 18782488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the seroprevalence and the demographic and clinical findings of fascioliasis patients in the Dicle River Basin in Turkey: a nine-year experience at a university hospital.
    Çiçek M; Yalçın K; Bilden A; Çakır F; Akpolat N
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):10831-10838. PubMed ID: 38039011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of Fasciola hepatica and F. gigantica in the endemic area of Guilan, Iran: Relationships between zonal overlap and phenotypic traits.
    Ashrafi K; Valero MA; Peixoto RV; Artigas P; Panova M; Mas-Coma S
    Infect Genet Evol; 2015 Apr; 31():95-109. PubMed ID: 25602718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased anti-Echinococcus granulosus antibody positivity in Fasciola hepatica infection.
    Kaya M; Beştaş R; Gırgın S; Çıçek M; Kaplan MA
    Turk J Gastroenterol; 2012 Aug; 23(4):339-43. PubMed ID: 22965504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.